Trials / Withdrawn
WithdrawnNCT01449448
Subacromial Injection With Corticosteroid Versus Nonsteroidal Anti-inflammatory Drugs (NSAID) in Shoulder Impingement Syndrome
A Double-blind Randomized Controlled Trial Comparing the Effects of Subacromial Injection With Corticosteroid Versus NSAID in Patients With Shoulder Impingement Syndrome
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Madigan Army Medical Center · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Injection with corticosteroid is one of the most common non-operative interventions in the treatment of subacromial impingement; however, its use is limited by its potential side effects (e.g. tendon rupture, subcutaneous atrophy, articular cartilage changes). The objective of this study was to compare the efficacy of subacromial injection of triamcinolone compared to injection of ketorolac. Thirty-two patients diagnosed with external shoulder impingement syndrome were included in this double-blinded randomized controlled clinical trial. Each patient was randomized into the Steroid group or NSAID group.
Detailed description
After a single injection into the subacromial space, the patients were instructed to perform home physical therapy and follow-up in four weeks. Each patient was evaluated in terms of arc of motion, Visual Analog Scale and the UCLA Shoulder Rating Scale. The outcome measures were taken at the preinjection state, immediately post injection, and at 4 weeks follow-up.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Ketorolac | Subacromial injection |
| DRUG | Triamcinolone | Subacromial Injection |
Timeline
- Start date
- 2000-09-01
- Primary completion
- 2005-09-01
- Completion
- 2005-09-01
- First posted
- 2011-10-10
- Last updated
- 2016-11-04
Source: ClinicalTrials.gov record NCT01449448. Inclusion in this directory is not an endorsement.